Keyword Search Year None20262025202420232022202120202019201820172016201520142013 May 29, 2026 Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer Read more » May 28, 2026 Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects Read more » May 27, 2026 Labcorp to Present at the Jefferies Global Healthcare Conference Read more » May 20, 2026 Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time Read more » May 12, 2026 Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems Read more » May 07, 2026 Labcorp Publishes 2025 Corporate Responsibility Report, Highlighting Progress in Sustainability, Access to Care and Employee Well-Being Read more » Apr 30, 2026 Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance Read more » Apr 22, 2026 Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA® Read more » Apr 15, 2026 Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes Read more » Apr 14, 2026 Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research Read more » Apr 13, 2026 Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide Read more » Apr 09, 2026 Labcorp Declares Quarterly Dividend Read more » Mar 31, 2026 Labcorp to Announce First Quarter Financial Results on April 30, 2026 Read more » Mar 19, 2026 Labcorp Completes Acquisition of Select Assets of Crouse Health’s Laboratory Alliance of Central New York’s Laboratory Business; Enters Agreement to Manage Crouse’s Inpatient Laboratory Read more » Feb 23, 2026 Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide Read more » Feb 17, 2026 Labcorp Announces 2025 Fourth Quarter and Full Year Results Read more » Feb 11, 2026 Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care Read more » Feb 09, 2026 Labcorp Announces Multi-Year Partnership with SOMOS IPA to Expand Access to High Quality, Affordable Laboratory Services for Patients Across New York State Read more » Feb 09, 2026 Labcorp Completes Acquisition of Select Assets of Empire City Laboratories Read more » Feb 09, 2026 Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors Read more » Jan 21, 2026 Labcorp Named One of the World's Most Admired Companies™ by Fortune Read more » Jan 15, 2026 Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 Read more » Jan 14, 2026 Labcorp Declares Quarterly Dividend Read more » Jan 13, 2026 Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk Read more »
